Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00318851 · ClinicalTrials.gov registry record · Phase 3

Carotid Artery Stenting With Protection Registry

A Phase 3 study, sponsored by Providence Health & Services.

Completed
Registry status
Phase 3
Development phase
62
Enrollment target

NCT00318851: Completed Phase 3 study, sponsored by Providence Health & Services.

NCT00318851 is a Phase 3 study that has completed, run by Providence Health & Services. The registered enrollment target is 62 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00318851, a Phase 3 study, has completed, sponsored by Providence Health & Services.

COMPLETED
Registry status
Phase 3
Development phase
62 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.

Interventions

  • DEVICE Carotid Stent with Distal Protection Device

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2003-09
Est. Completion 2007-08
Phase Phase 3
Providence Health & Services

69 total trials

What the finished NCT00318851 record still lists

NCT00318851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Carotid Stent with Distal Protection Device is the first listed.

NCT00318851 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00318851 about?

NCT00318851 is a clinical study titled "Carotid Artery Stenting With Protection Registry". The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.

What is the current status of trial NCT00318851?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2003-09. Estimated completion is 2007-08.

What interventions are being tested in trial NCT00318851?

The interventions under investigation include: Carotid Stent with Distal Protection Device (DEVICE).

Who is sponsoring clinical trial NCT00318851?

This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00318851's enrollment target sits among peer trials

62 1802nd of 2000 higher than 198 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00318851, the US trial registry maintained by the National Library of Medicine. NCT00318851 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.